Last reviewed · How we verify
NCT02357251
Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients
NA trial testing Enhanced recovery protocol in Laparotomy in 40 participants. Completed in 3 July 2017.
3 July 2017
Quick facts
| Lead sponsor | Case Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 12 December 2014 |
| Primary completion | 3 July 2017 |
| Estimated completion | 3 July 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Enhanced recovery protocol
Conditions studied
- Laparotomy — all drugs for Laparotomy →
- Gynecologic Diseases — all drugs for Gynecologic Diseases →
Sponsor
Case Comprehensive Cancer Center — full company profile →
Who can join
18 and older, female only, with Laparotomy or Gynecologic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-blinded randomized control trial comparing the current perioperative care of the investigators gynecologic oncology patients with a standardized perioperative "enhanced recovery" pathway. Adult patients undergoing laparotomy by one of the gynecologic oncology surgeons will be eligible to participate. The primary outcome will be length of hospitalization including any days of readmission in the 30 days post-operatively. Secondary outcomes will include 30-day readmission rate, complications, quality of recovery, and pain control.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Strategies for the removal of short-term indwelling urethral catheters in adults.
Ellahi A, Stewart F, Kidd EA, Griffiths R, et al · · 2021 · cited 18× · PMID 34184246 · DOI 10.1002/14651858.cd004011.pub4
Verify or expand the search:
- PubMed search for NCT02357251
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Enhanced recovery protocol
Trials testing the same drug.
- NCT03382210 — Impact of a Colorectal Enhanced Recovery Program Implementation on Clinical Outcomes and Institutional Costs · completed
Other recruiting trials for Laparotomy
Currently open trials in the same condition.
- NCT06559969 — IV vs Epidural Opioids + Epidural Local Anesthetic for Laparotomy Analgesia · Phase 2, PHASE3 · recruiting
- NCT07233603 — S-TAP vs RSB in Midline Abdominal Incision Laparotomy · NA · active not recruiting
- NCT07233629 — M-TAPA vs RSB in Midline Abdominal Incision Laparotomy · NA · active not recruiting
- NCT04985695 — Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy · NA · recruiting
- NCT04256798 — Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery · Phase 3 · recruiting
Other Case Comprehensive Cancer Center trials
Trials by the same sponsor.
- NCT06811454 — Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) · NA · not yet recruiting
- NCT07167056 — Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer · NA · recruiting
- NCT07084779 — Investigation of Impact of AI on Prostate Cancer Workflow · NA · recruiting
- NCT06904482 — Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood · Phase 2 · recruiting
- NCT07044362 — Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02357251 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Case Comprehensive Cancer Center
- Last refreshed: 12 July 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02357251.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing